Results 181 to 190 of about 485,556 (376)

Corrigendum to "Exosomes as novel tools for renal cell carcinoma therapy, diagnosis, and prognosis" [Heliyon Volume 10, Issue 12, June 30, 2024, Article e32875]. [PDF]

open access: yesHeliyon
Razavinia A   +8 more
europepmc   +1 more source

CO2, Fiber, and UV Direct Laser Writing of Graphene for Flexible EMI Shielding Applications: A Comparative Study

open access: yesJournal of Applied Polymer Science, EarlyView.
Direct laser wrtitng of graphene with three different laser sources for fabrication of electromagnetic shields. ABSTRACT As electronic devices become an inseparable part of modern life, the challenge of electromagnetic interference (EMI) continues to grow.
Mahsa Barjinikhabbaz   +5 more
wiley   +1 more source

Evaluating Medical Text Summaries Using Automatic Evaluation Metrics and LLM-as-a-Judge Approach: A Pilot Study. [PDF]

open access: yesDiagnostics (Basel)
Vasilev Y   +8 more
europepmc   +1 more source

Descriptive, comparative, and functional anatomy of the facial musculature in cattle (Bos taurus)

open access: yesThe Anatomical Record, EarlyView.
Abstract Facial expressions can provide insight into animal emotions and pain, but no standardized system for assessing the entire facial display in cattle (Bos taurus Linnaeus) exists. The Facial Action Coding System (FACS), originally developed for humans, identifies distinct facial movements based on mimetic muscles.
Maja Söderlind   +6 more
wiley   +1 more source

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The aim of this study was to compare differences in clinical response, drug survival, and adverse event rates between anakinra and canakinumab in VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Methods This multicenter international study includes patients with VEXAS from France, Israel, and Italy treated with ...
Tali Eviatar   +35 more
wiley   +1 more source

Impact of evolving treatment patterns on interstitial lung disease progression in systemic sclerosis using the EUSTAR database

open access: yesArthritis &Rheumatology, Accepted Article.
Background The treatment landscape for systemic sclerosis‐associated interstitial lung disease (SSc‐ILD) has evolved with increasing immunosuppressive (IST) and anti‐fibrotic therapies available. However, their real‐world use remains unclear. Objectives To analyze treatment trends and the effect of IST and anti‐fibrotic therapies on ILD progression ...
Corrado Campochiaro   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy